Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 210 participants.

Also called NCT01914432

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 210 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01914432
Other papers using this trial's data
  • Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III Study Clinical therapeutics, 2018-05 DOI, PubMed 29673890

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01914432. Randomized; quadruple masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia
Condition
Hyperlipidemia
Condition
Hypertension
Intervention (Drug)
YH16410
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Telmisartan
Intervention (Drug)
YH16410 placebo
Intervention (Drug)
Rosuvastatin placebo
Intervention (Drug)
Telmisartan placebo
Lead sponsor
Yuhan Corporation (class: industry)

Record details

Record id
cardio:ct-nct01914432
Content hash
7fb0c53a4db3ae434078e6f496b64957298730430280456582ff4c2d84637777